Instituto de Investigación en Enfermedades Crónico Degenerativas, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada # 950, Colonia Independencia, Guadalajara 44340, Jalisco, Mexico.
Laboratorio de Inmunología Traslacional, Departamento de Biología Celular y Molecular, Centro Universitario de Ciencias Biológicas y Agropecuarias, Universidad de Guadalajara, Camino Ramón Padilla Sánchez # 2100, Zapopan 45200, Jalisco, Mexico.
Int J Mol Sci. 2024 Aug 12;25(16):8775. doi: 10.3390/ijms25168775.
Cervical cancer (CC) poses a significant health burden, particularly in low- and middle-income countries. NK cells play a crucial role against CC; however, they can become exhausted and lose their cytotoxic capacity. This work explores the expression of costimulatory receptors (ICOS, 4-1BB, OX-40) in exhausted NK cells from CC patients. Peripheral blood and tumor biopsies were collected, and flow cytometry was used to evaluate the expression of costimulatory receptors in exhausted NK cells. There is an increase of peripheral exhausted NK cells (PD-1TIGIT) in CC patients; this subpopulation has a selectively increased expression of the costimulatory receptors ICOS and 4-1BB. An exhausted population is also highly increased in tumor-infiltrating NK cells, and it shows a dramatically increased expression of the costimulatory receptors ICOS (>15×) and 4-1BB (>10×) compared to peripheral NK cells. The exhausted cells, both in the periphery and in the tumor infiltrating lymphocytes (TILs), are also more likely than non-exhausted NK cell populations (PD-1TIGIT) to express these costimulatory receptors; increases ranging from 2.0× ICOS, 2.4× 4-1BB, and 2.6× OX-40 in CD56 PBMCs to 1.5× ICOS, 5× 4-1BB, and 10× OX-40 in TILs were found. Our study demonstrates for the first time the increased expression of the costimulatory receptors ICOS, 4-1BB, and OX-40 in peripheral CD56, CD56, and tumor-infiltrating NK cells in CC. Targeting these receptors for stimulation could reverse exhaustion and be a promising immunotherapy strategy.
宫颈癌(CC)对健康造成重大负担,尤其在中低收入国家。NK 细胞在对抗 CC 方面发挥关键作用;然而,它们可能会衰竭并丧失细胞毒性。本工作探讨了 CC 患者衰竭 NK 细胞中共刺激受体(ICOS、4-1BB、OX-40)的表达。采集外周血和肿瘤活检,流式细胞术评估共刺激受体在衰竭 NK 细胞中的表达。CC 患者外周血中衰竭 NK 细胞(PD-1TIGIT)增加;该亚群共刺激受体 ICOS 和 4-1BB 的表达选择性增加。肿瘤浸润 NK 细胞中也高度增加衰竭细胞群,与外周 NK 细胞相比,其共刺激受体 ICOS(>15×)和 4-1BB(>10×)表达显著增加。与非衰竭 NK 细胞群(PD-1TIGIT)相比,在外周和肿瘤浸润淋巴细胞(TIL)中衰竭细胞更有可能表达这些共刺激受体;CD56 PBMCs 中 ICOS 增加 2.0×、4-1BB 增加 2.4×、OX-40 增加 2.6×,而 TIL 中 ICOS 增加 1.5×、4-1BB 增加 5×、OX-40 增加 10×。本研究首次证明了 CC 患者外周血 CD56、CD56 和肿瘤浸润 NK 细胞中共刺激受体 ICOS、4-1BB 和 OX-40 的表达增加。针对这些受体进行刺激可能逆转衰竭,是一种有前途的免疫治疗策略。